Full Professor(heuristic)

Ovarian cancer diagnosis and treatment · Reproductive Medicine

Compare more Reproductive Medicine professors.

h-index18
i10-index21
Publications55
Citations2,877

Grants

5 total · 0 active

NIH #T32CA113951

Interdisciplinary Training in Cancer Epidemiology at UB

Amount
$100K–$200K
Period
2005-04-012023-08-31
PIs
2

Awarded at STATE UNIVERSITY OF NEW YORK AT BUFFALO

NIH #P50CA159981

RPCI-UPCI Ovarian Cancer SPORE

Amount
$1M–$2M
Period
2013-09-182021-06-30
PIs
2

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

NIH #R01CA188900

Novel immunological biomarkers ovarian cancer prognosis

Amount
$600K–$700K
Period
2015-06-012020-05-31
PIs
2

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

5 total · 0 active

NIH #T32CA113951

Interdisciplinary Training in Cancer Epidemiology at UB

Amount
$100K–$200K
Period
2005-04-012023-08-31
PIs
2

Awarded at STATE UNIVERSITY OF NEW YORK AT BUFFALO

NIH #P50CA159981

RPCI-UPCI Ovarian Cancer SPORE

Amount
$1M–$2M
Period
2013-09-182021-06-30
PIs
2

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

NIH #R01CA188900

Novel immunological biomarkers ovarian cancer prognosis

Amount
$600K–$700K
Period
2015-06-012020-05-31
PIs
2

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

NIH #R25CA113951

Interdisciplinary Training in Cancer Epidemiology at UB

Amount
$200K–$300K
Period
2007-06-112016-08-31
PIs
2

Awarded at STATE UNIVERSITY OF NEW YORK AT BUFFALO

NIH #R01CA126841

Regulatory T Cell Function in Ovarian Cancer

Amount
$600K–$700K
Period
2009-07-012014-05-31
PIs
1

Awarded at ROSWELL PARK CANCER INSTITUTE CORP

Recent Public Signals

  1. New preprint: Data from A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk2023-03-31
  2. New paper: Supplementary Table 1 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers2023-03-31

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-09

Data may not be current

Find elsewhere

Professor Insights

Career Trajectory